We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$345M
AUM Growth
-$28.9M
Cap. Flow
-$37.8M
Cap. Flow %
-10.94%
Top 10 Hldgs %
29.4%
Holding
780
New
93
Increased
153
Reduced
203
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 13.26%
2 Healthcare 12.29%
3 Financials 8.86%
4 Consumer Discretionary 8.79%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
26
AT&T
T
$164B
$3.33M 0.97%
154,830
+1,660
+1% +$37.1K
ATVI
27
DELISTED
Activision Blizzard
ATVI
$3.26M 0.94%
40,220
+8,791
+28% +$713K
INTC icon
28
Intel
INTC
$413B
$3.21M 0.93%
61,907
+18,327
+42% +$953K
OIH icon
29
VanEck Oil Services ETF
OIH
$1.97B
$3.2M 0.93%
32,750
CSCO icon
30
Cisco
CSCO
$443B
$2.74M 0.79%
69,646
-50,284
-42% -$2.19M
DB icon
31
PUT
Deutsche Bank
DB
$66.6B
$2.7M 0.78%
13,683
-1,133
-8% -$10.6K
NOBL icon
32
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$2.55M 0.74%
70,824
-1,062
-1% -$38.1K
UBS icon
33
CALL
UBS Group
UBS
$170B
$2.37M 0.69%
31,888
+10,269
+47% +$123K
F icon
34
Ford
F
$60.9B
$2.37M 0.69%
355,712
+124,952
+54% +$846K
WDIV icon
35
State Street SPDR S&P Global Dividend ETF
WDIV
$278M
$2.36M 0.68%
44,378
-668
-1% -$36.5K
BMY icon
36
Bristol-Myers Squibb
BMY
$129B
$2.21M 0.64%
36,583
+18,001
+97% +$1.08M
QGEN icon
37
Qiagen
QGEN
$8.62B
$2.09M 0.61%
70,828
+57,405
+428% +$2.98M
OTIS icon
38
Otis Worldwide
OTIS
$27.9B
$2.01M 0.58%
32,165
+1,143
+4% +$69.9K
CRM icon
39
Salesforce
CRM
$154B
$1.91M 0.55%
7,602
-120
-2% -$26.3K
JPM icon
40
JPMorgan Chase
JPM
$916B
$1.72M 0.5%
17,883
-3,197
-15% -$314K
IBM icon
41
IBM
IBM
$213B
$1.69M 0.49%
14,568
-1,518
-9% -$179K
STX icon
42
Seagate
STX
$174B
$1.67M 0.48%
33,964
-32,748
-49% -$1.54M
TMO icon
43
Thermo Fisher Scientific
TMO
$214B
$1.66M 0.48%
3,765
-31
-0.8% -$12.8K
LMT icon
44
Lockheed Martin
LMT
$131B
$1.54M 0.44%
4,007
+2,890
+259% +$1.1M
COR icon
45
Cencora
COR
$62B
$1.53M 0.44%
15,820
+15,803
+92,959% +$1.57M
MO icon
46
Altria Group
MO
$125B
$1.51M 0.44%
39,195
+34,610
+755% +$1.44M
SJM icon
47
J.M. Smucker
SJM
$13.5B
$1.51M 0.44%
13,080
+9,157
+233% +$1.02M
CHTR icon
48
Charter Communications
CHTR
$17.3B
$1.48M 0.43%
2,370
+1,546
+188% +$912K
VZ icon
49
Verizon
VZ
$197B
$1.48M 0.43%
24,804
+9,190
+59% +$534K
LQD icon
50
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$1.4M 0.41%
10,422
-11,256
-52% -$1.53M

Similar funds

Exane Derivatives's Q3 2020 Portfolio in Review

As of Q3 2020, Exane Derivatives held 780 positions worth $345M, down 7.7% from $374M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Exane Derivatives withdrew a net $37.8M in Q3 2020, closing 29 positions and reducing 203 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $8.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Exane Derivatives opened a new position in iShares MSCI Turkey ETF worth $10.6M.

  • Exane Derivatives's largest Q3 2020 buy was iShares MSCI Turkey ETF: 537,062 shares worth $10.6M.
  • Exane Derivatives added most to State Street Energy Select Sector SPDR ETF in Q3 2020, an estimated $15.1M increase.
  • Exane Derivatives's biggest Q3 2020 reduction was Linde, cutting an estimated $7.17M.
  • Exane Derivatives fully exited iShares MSCI Emerging Markets ETF in Q3 2020, selling an estimated $8.3M.
  • Exane Derivatives's ten largest holdings make up 29% of its $345M portfolio in Q3 2020.
  • Exane Derivatives opened 93 new positions and closed 29 in Q3 2020.
  • Exane Derivatives's portfolio value fell 7.7% quarter-over-quarter to $345M.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.